Cargando…

Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma

BACKGROUND: The mutation-based analysis of circulating tumor DNA (ctDNA) is a promising diagnostic tool for clinical oncology. However, it has low success rate because many cancer patients do not have detectable ctDNA in the bloodstream. AIM: To evaluate whether preoperative tumor irradiation result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuligina, Ekaterina, Moiseyenko, Fedor, Belukhin, Sergey, Stepanova, Ekaterina, Zakharova, Maria, Chernobrivtseva, Vera, Aliev, Ikram, Sharabura, Tatiana, Moiseyenko, Vladimir, Aleksakhina, Svetlana, Laidus, Tatiana, Martianov, Aleksandr, Kholmatov, Maksim, Whitehead, Aldon, Yanus, Grigoriy, Imyanitov, Evgeny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716992/ https://www.ncbi.nlm.nih.gov/pubmed/35070740 http://dx.doi.org/10.5306/wjco.v12.i12.1215

Ejemplares similares

Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
por: Moiseyenko, Fedor V., et al.
Publicado: (2022)

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1
por: Mitiushkina, Natalia V., et al.
Publicado: (2022)

Hereditary cancer syndromes
por: Imyanitov, Evgeny N, et al.
Publicado: (2023)

Lack of Response to Vemurafenib in Melanoma Carrying BRAF K601E Mutation
por: Moiseyenko, Fedor V., et al.
Publicado: (2019)

Drug therapy for hereditary cancers
por: Imyanitov, Evgeny N, et al.
Publicado: (2011)

Resistance mechanisms to drug therapy in breast cancer and other solid tumors: An opinion
por: Moiseenko, Fedor, et al.
Publicado: (2017)

Tumor acidity: From hallmark of cancer to target of treatment
por: Bogdanov, Alexey, et al.
Publicado: (2022)

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine
por: Sokolova, Tatiana N., et al.
Publicado: (2021)

Molecular testing for colorectal cancer: Clinical applications
por: Imyanitov, Evgeny, et al.
Publicado: (2021)

Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer
por: Mitiushkina, Natalia V., et al.
Publicado: (2022)

“Lazarus Response” to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion
por: Moiseyenko, Vladimir M, et al.
Publicado: (2018)

Integration of the blood test into the low-dose computed tomography lung cancer screening: reliable discrimination between malignant and non-malignant radiographic findings
por: Kuligina, Ekaterina S., et al.
Publicado: (2021)

Molecular Analysis of Biliary Tract Cancers with the Custom 3′ RACE-Based NGS Panel
por: Mitiushkina, Natalia V., et al.
Publicado: (2023)

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation p.T632I
por: Orlova, Kristina V., et al.
Publicado: (2019)

Cancer Therapy Guided by Mutation Tests: Current Status and Perspectives
por: Aleksakhina, Svetlana N., et al.
Publicado: (2021)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
por: Martianov, Aleksandr S., et al.
Publicado: (2023)

Oxygen Supply System Management in an Overweight Adult after 12 Months in Antarctica—Study Case
por: Radziejowska, Maria, et al.
Publicado: (2021)

Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1-Driven Breast Cancer Patients
por: Sokolenko, Anna P., et al.
Publicado: (2023)

The Association between Gly460Trp-Polymorphism of Alpha-Adducin 1 Gene (ADD1) and Arterial Hypertension Development in Ukrainian Population
por: Yermolenko, Svitlana, et al.
Publicado: (2021)

Annulation of 1H-pyrrole-2,3-diones by thioacetamide: an approach to 5-azaisatins
por: Kobelev, Aleksandr I, et al.
Publicado: (2019)

Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas
por: Tiurin, Vladislav I., et al.
Publicado: (2023)

Hereditary Breast-Ovarian Cancer Syndrome in Russia
por: Sokolenko, A.P., et al.
Publicado: (2010)

Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study
por: Orlov, Sergey V., et al.
Publicado: (2021)

Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma
por: Moiseyenko, Andrey, et al.
Publicado: (2020)

Hormonal Signaling during dPCD: Cytokinin as the Determinant of RNase-Based Self-Incompatibility in Solanaceae
por: Zakharova, Ekaterina, et al.
Publicado: (2023)

Erratum to: Antarctica challenges the new horizons in predictive, preventive, personalized medicine: preliminary results and attractive hypotheses for multi-disciplinary prospective studies in the Ukrainian “Akademik Vernadsky” station
por: Moiseyenko, Yevhen V., et al.
Publicado: (2016)

Antarctica challenges the new horizons in predictive, preventive, personalized medicine: preliminary results and attractive hypotheses for multi-disciplinary prospective studies in the Ukrainian “Akademik Vernadsky” station
por: Moiseyenko, Yevhen V., et al.
Publicado: (2016)

Facile regiodivergent synthesis of spiro pyrrole-substituted pseudothiohydantoins and thiohydantoins via reaction of [e]-fused 1H-pyrrole-2,3-diones with thiourea
por: Kobelev, Aleksandr I, et al.
Publicado: (2019)

Synthesis of 1,4-benzothiazinones from acylpyruvic acids or furan-2,3-diones and o-aminothiophenol
por: Stepanova, Ekaterina E, et al.
Publicado: (2020)

Immunosuppressive Treatment for Lupus Nephritis: Long-Term Results in 178 Patients
por: Zakharova, Elena V., et al.
Publicado: (2016)

Approaches to Formaldehyde Measurement: From Liquid Biological Samples to Cells and Organisms
por: Lipskerov, Fedor A., et al.
Publicado: (2022)

ALK, ROS1, RET and NTRK1–3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers
por: Mulkidjan, Rimma S., et al.
Publicado: (2023)

Rapid Improvement of the Performance Status and Reduction of the Tumor Size in KRAS-Mutated Colorectal Cancer Patient Receiving Binimetinib, Hydroxychloroquine, and Bevacizumab
por: Orlov, Sergey V., et al.
Publicado: (2020)

Oxidative Stress and Free Radical Processes in Tumor and Non-Tumor Obstructive Jaundice: Influence of Disease Duration, Severity and Surgical Treatment on Outcomes
por: Silina, Ekaterina Vladimirovna, et al.
Publicado: (2022)

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells
por: Dmitrieva, Maria D., et al.
Publicado: (2020)

Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
por: Yudintceva, Natalia, et al.
Publicado: (2021)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
por: Isakova-Sivak, Irina, et al.
Publicado: (2022)

Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors
por: Imyanitov, Evgeny, et al.
Publicado: (2021)

Incidental germline findings during molecular profiling of tumor tissues for precision oncology: molecular survey and methodological obstacles
por: Lebedeva, Alexandra, et al.
Publicado: (2022)

Discovery of a novel role of tumor suppressor PDCD4 in stimulation of translation termination
por: Shuvalova, Ekaterina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3e3n8un8ebci2chtafhrrsgp0m